Michael Beazely

Associate Professor

University of Waterloo

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Michael Beazely is an Associate Professor at the University of Waterloo in Canada. His research areas include the neuroprotective effects of trehalose, opioid-related stigma in healthcare, and community pharmacy practices, particularly regarding naloxone distribution and cannabis education. He has authored several recent articles exploring topics such as racial and ethnic bias among pharmacists and the impact of endocannabinoids on amyloid-beta toxicity.

Articles (13)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (1)

PRAVEEN Nekkar Rao

Associate Professor and Cross-Appointed to Departments of Chemistry and Biology

University of Waterloo

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michael Beazely

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Trehalose, but not other sugars, protects HT22 cells against amyloid-beta toxicity

Adapting the Opening Minds Stigma Scale for Healthcare Providers to Measure Opioid-Related Stigma

Estimating implicit and explicit racial and ethnic bias among community pharmacists in Canada

An economic evaluation of community pharmacy–dispensed naloxone in Canada

Differential Effects of Endocannabinoids on Amyloid-Beta Aggregation and Toxicity

Drug–Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data

Assessing the impact of a cannabis course on pharmacy students’ understanding, beliefs and preparedness regarding medical and recreational cannabis

Frequently asked questions about naloxone: Part 1

Investigating Community Pharmacy Take Home Naloxone Dispensing during COVID-19: The Impact of One Public Health Crisis on Another

What Is Known about Community Pharmacy-Based Take-Home Naloxone Programs and Program Interventions? A Scoping Review.

Pseudopeptide Amyloid Aggregation Inhibitors: In Silico, Single Molecule and Cell Viability Studies.

The status of naloxone in community pharmacies across Canada.

Canadian national consensus guidelines for naloxone prescribing by pharmacists.

Collaborators (1)

PRAVEEN Nekkar Rao

Make your next move.